GJ

Gurumukhadas Jamandas Nanjani

Active Director Designated Partner DIN 10050642
DIN 10050642 First appointment Feb 2023 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurumukhadas Jamandas Nanjani

Data last updated:

Gurumukhadas Jamandas Nanjani is a Designated Partner at Decryptomics Biotech Llp (since 2023). The company operates in Life Sciences.

DIN 10050642
Primary Designation Designated Partner
Industry Life Sciences
First Appointment 20 Feb 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Feb 20232023Active

Board colleagues of Gurumukhadas Jamandas Nanjani

NameDINCompanyDesignation
Sandhya Gurumukhadas Nanjani10050643Decryptomics Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Decryptomics Biotech Llp
Premium access

Shareholding and investment profile for Gurumukhadas Jamandas Nanjani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurumukhadas Jamandas Nanjani

Gurumukhadas Jamandas Nanjani currently holds 1 directorship: Decryptomics Biotech Llp (Designated Partner, since 20 Feb 2023).

Gurumukhadas Jamandas Nanjani was first appointed on 20 Feb 2023 as Designated Partner at Decryptomics Biotech Llp.

The current boards of Gurumukhadas Jamandas Nanjani's companies include Sandhya Gurumukhadas Nanjani (Decryptomics Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available